112493 ⎘
Preparation of peptides or proteins Glycopeptides, glycoproteins
ANTI-MCAM ANTIBODIES AND ASSOCIATED METHODS OF USE
#302Follower bar assembly for a bender
#303Activated formylglycine-generating enzymes and methods of producing and using the same
#304REDUCTION OF LIPASE ACTIVITY IN PRODUCT FORMULATIONS
#305Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
#306Enzymes and methods for cleaving N-glycans from glycoproteins
#307Cell Line for Producing Recombinant Glycoproteins with Di-Antennary N-Glycans, Methods Using the Same, and Recombinant Glycoproteins
#308Chemoenzymatic glycoengineering of antibodies and FC fragments thereof
#309Methods for increasing mannose content of recombinant proteins
#310ANTIBODY COMPOSITION-PRODUCING CELL
#311Compositions and methods for reducing fucosylation of glycoproteins in insect cells and methods of use thereof for production of recombinant glycoproteins
#312Recombinant α-galactosidase A for treatment of Fabry disease
#313Medium containing uridine and N-acetyl-D-mannosamine
#314Acinetobacter o-oligosaccharyltransferases and uses thereof
#315Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
#316Means and methods for site-specific functionalization of polypeptides
#317A CELL-BASED ARRAY PLATFORM
#318INCREASING ACTIVITY OF 2? FUCOSYLLACTOSE TRANSPORTERS ENDOGENOUS TO MICROBIAL CELLS
#319INCREASING EXPORT OF 2? FUCOSYLLACTOSE FROM MICROBIAL CELLS THROUGH THE EXPRESSION OF A HETEROLOGOUS NUCLEIC ACID
#320In vivo production of proteins
#321Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
#322Modified host cells and hybrid oligosaccharides for use in bioconjugate production
#323Production of Glycoproteins Having Increased N-Glycosylation Site Occupancy
#324Method for preparing collagen having regeneration and repair effects from Wharton's Jelly mesenchymal stem cells
#325Recombinant polypeptide production methods
#326Recombinant lubricin
#327RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME
#328Variable diameter bioreactors
#329Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
#330Human antibody-producing non-human animal and method for preparing human antibodies using same
#331Anti-PD-L1-anti-TIM-3 bispecific antibodies
#332MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
#333Protease deficient filamentous fungal cells and methods of use thereof
#334Method for obtaining antibody
#335Yeast strains producing mammalian-like complex n-glycans
#336METHOD FOR OPTIMIZING THE ASSEMBLY AND PRODUCTION OF HETERO-MULTIMERIC PROTEIN COMPLEXES
#337MODIFIED GLYCOPROTEIN, PROTEIN-CONJUGATE AND PROCESS FOR THE PREPARATION THEREOF
#338Protein production in microorganisms of the phylum labyrinthulomycota
#339Serum albumin binding molecules
#340Production of N-glycoproteins for enzyme assisted glycomodification
#341Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
#342Methods for modifying human antibodies by glycan engineering
#343In vitro glycosylation of proteins and enzymes
#344Designer α 6-fucosidase mutants enable direct core fucosylation of intact N-glycopeptides and N-glycoproteins
#345METHODS FOR MODULATING PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEIN THERAPEUTICS USING MONOSACCHARIDES AND OLIGOSACCHARIDES
#346Means and methods for modifying multiple alleles
#347Site-specific crosslinking of antibodies
#348MICROBIAL PLATFORM FOR PRODUCTION OF GLYCOSYLATED COMPOUNDS
#349Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose
#350Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
#351Aldehyde tags, uses thereof in site-specific protein modification
#352Means and methods for generating complex glycans derived from fungal engineered hosts
#353Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#354Multi-copy strategy for high-titer and high-purity production of multi-subunit proteins such as antibodies in transformed microbes such as
#355Methods for modifying human antibodies by glycan engineering
#356PROCESS FOR MANIPULATING THE LEVEL OF GLYCAN CONTENT OF A GLYCOPROTEIN
#357Control of protein glycosylation by culture medium supplementation and cell culture process parameters
#358IL-18 binding molecules
#359Compositions and methods for protein glycosylation
#360Production of recombinant vaccine in by enzymatic conjugation
#361Enzymes and methods for cleaving N-glycans from glycoproteins
#362Enzymes for trimming of glycoproteins
#363Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#364Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#365Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative Compound
#366Methods related to biologics
#367FUCOSYLATION-DEFICIENT CELLS
#368Cells producing Fc containing molecules having altered glycosylation patterns and methods and use thereof
#369Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
#370CELL CULTURE PROCESS FOR MAKING A GLYCOPROTEIN
#371Methods for increasing mannose content of recombinant proteins
#372Generation and comparative kinetic analysis of new glycosynthase mutants from endoglycosidases for antibody glycoengineering
#373Transglycosylation of endo-S and endo-S mutants for antibody glycosylation remodeling
#374Anti-HER2 glycoantibodies and uses thereof
#375MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES
#376Methods of producing glycosylated proteins
#377Method for preparing antibodies having improved properties
#378Method of manufacturing a protein by perfusion in media with a low amino acid concentration
#379Method of using carbohydrate esters as inducers for gene expression
#380Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same
#381MONOCLONAL ANTIBODY PRODUCTION BY EBV TRANSFORMATION OF B CELLS
#382METHODS FOR MODULATING PRODUCTION PROFILES OF RECOMBINANT PROTEINS
#383Methods of minimizing glycoprotein agregation in CHO cell production
#384Modified Polynucleotides for the production of biologics and proteins associated with human disease
#385Sialylated Glycoproteins
#386Cell-free glycoprotein synthesis (CFGpS) in prokaryotic cell lysates enriched with components for glycosylation
#387Methods for glycoprotein remodeling using endoglycosidase mutants
#388Anti-PD-L1-anti-TIM-3 bispecific antibodies
#389Cleavage of fucose in N-glycans
#390COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY
#391Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from a β(1,4)-n-acetylgalactosaminyltransferase
#392Activated formylglycine-generating enzymes and methods of producing and using the same
#393CELL LINE 3M
#394CELL EXPRESSION SYSTEM
#395Enzymatic conjugation of antibodies
#396Cell culture process
#397Cells producing glycoproteins having altered N- and O-glycosylation patterns and methods and use thereof
#398Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#399Reduction of lipase activity in product formulations
#400Glycosylation method
#401Mutated sialidases
#402Manganese supplementation for control of glycosylation in mammalian cell culture process
#403METHODS AND KITS FOR CANCER ANTIGEN AND HEPARAN SULFATE IMAGING
#404SMALL SCALE CULTIVATION METHOD FOR SUSPENSION CELLS
#405Expression of modified glycoproteins and glycopeptides
#406RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES
#407Systems and methods for predicting glycosylation on proteins
#408CELL EXPRESSION SYSTEM
#409RECOMBINANT PRODUCTION OF MIXTURES OF ANTIBODIES
#410Methods for controlling fucosylation levels in proteins
#411Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and applications thereof
#412METHODS AND COMPOSITIONS FOR ENZYME-MEDIATED SITE-SPECIFIC RADIOLABELING OF GLYCOPROTEINS
#413ENZYMATIC CONJUGATION OF POLYPEPTIDES
#414Endoglycosidase mutants for glycoprotein remodeling and methods of using it
#415Acinetobacter O-oligosaccharyltransferases and uses thereof
#416Method for production of heparin and heparan sulfate
#417MODIFIED CANCER CELL LINES AND USES THEREOF
#418V1/V2 fragments of a HIV-1 envelope glycoprotein
#419Cell culture medium and methods for enhancing recombinant antibody purity
#420Pharmaceutical preparation comprising recombinant HcG
#421Method for rapid in vitro synthesis of glycoproteins via recombinant production of -glycosylated proteins in prokaryotic cell lysates
#422Feed mixing device and its use
#423METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS
#424Compositions and methods for protein glycosylation
#425Methods and means for the production of Ig-like molecules
#426N-glycosylation
#427Variable diameter bioreactors
#428High affinity antibody antagonists of interleukin-13 receptor alpha 1
#429Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#430METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES
#431Process for manipulating the level of glycan content of a glycoprotein
#432LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS
#433Glycan-based antibody-drug conjugates
#434METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS
#435Production Of Glycoproteins Using Manganese
#436Means and methods for site-specific functionalization of polypeptides
#437In vivo production of proteins
#438O-glycan sialylated recombinant glycoproteins and cell lines for producing the same
#439Efficient selectivity of recombinant proteins
#440Copper supplementation for control of glycosylation in mammalian cell culture process
#441Methods and means for the production of Ig-like molecules
#442GLYCOSYLATION MUTANTS FOR PRODUCING GALACTOSE-FREE AND FUCOSE-FREE POLYPEPTIDES
#443Polypeptides With Enhanced Anti-Inflammatory And Decreased Cytotoxic Properties And Relating Methods
#444De-mannosylation of phosphorylated N-glycans
#445METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING DISSOLVED OXYGEN
#446Cell culture medium
#447Aqueous composition
#448Protease deficient filamentous fungal cells and methods of use thereof
#449PLANT CELLS AND PLANTS EXPRESSING FUCOSYL TRANSFERASE FOR ANIMAL-TYPE SUGAR CHAIN ADDING FUNCTION
#450Anti-EGFR antibody and uses of same
#451Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
#452GALACTOENGINEERED IMMUNOGLOBULIN 1 ANTIBODIES
#453METHOD OF MODULATING THE ACTIVITY OF FUNCTIONAL IMMUNE MOLECULES
#454Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
#455Modified lipopolysaccharide glycoform and method of use
#456METHODS OF CELL CULTURE
#457Methods for generating engineered enzymes
#458ANTI-CD25 ANTIBODIES AND THEIR USES
#459CELL LINE 3M
#460Modified host cells and hybrid oligosaccharides for use in bioconjugate production
#461Process for the modification of a glycoprotein using a β-(1,4)-N-acetylgalactosaminyl transferase or a mutant thereof
#462Methods of cell culture
#463METHODS FOR MODULATING PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEIN THERAPEUTICS USING COBALT
#464Hydrolysis of mannose-1-phospho-6-mannose linkage to phospho-6-mannose
#465Anti-OSPA antibodies and methods of use
#466Antibody gene expression-secretion system
#467Integrated continuous manufacturing of therapeutic protein drug substances
#468Fucosylation-deficient cells
#469Methods of cell culture
#470System for rapid continuous manufacturing of monoclonal antibodies
#471COMPOSITION FOR PREVENTING OR TREATING STAPHYLOCOCCUS AUREUS INFECTION
#472MACROPHAGE ACTIVATING FACTOR FOR PHARMACEUTICAL COMPOSITIONS
#473Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compound
#474Oligosaccharide modification and labeling of proteins
#475Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins
#476METHOD FOR MODULATING GALACTOSYLATION OF RECOMBINANT PROTEIN THROUGH OPTIMIZATION OF CULTURE MEDIUM
#477METHOD OF PRODUCTION OF RECOMBINANT GLYCOPROTEINS WITH INCREASED CIRCULATORY HALF-LIFE IN MAMMALIAN CELLS
#478Production of glycoproteins with mammalian-like N-glycans in filamentous fungi
#479Process and methods for efficient manufacturing of highly pure asymmetric antibodies in mammalian cells
#480COMPOSITIONS AND METHODS FOR PRODUCING GLYCOPROTEINS
#481USE OF METAL IONS FOR MODULATION OF PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEINS
#482Serum albumin binding molecules
#483Methods for producing recombinant glycoproteins with modified glycosylation
#484PROTEIN PRODUCTION IN MICROORGANISMS OF THE PHYLUM LABYRINTHULOMYCOTA
#485METHODS FOR MODULATING PROTEIN GLYCOSYLATION PROFILES OF RECOMBINANT PROTEIN THERAPEUTICS USING MONOSACCHARIDES AND OLIGOSACCHARIDES
#486METHODS TO CONTROL PROTEIN HETEROGENEITY
#487Process for the modification of a glycoprotein using a glycosyltransferase that is or is derived from A β(1,4)-N-acetylgalactosaminyltransferase
#488METHOD FOR PREPARING RECOMBINANT GLYCOPROTEIN HAVING HIGH SIALIC ACID CONTENT, THROUGH GLYCOSPHINGOLIPID SYNTHESIS CYCLE CONTROL
#489MODULATED LYSINE VARIANT SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME
#490Aldehyde tags, uses thereof in site-specific protein modification
#491Hydrolysis resistant sialic acid derivatives and methods for their use
#492METHODS OF INCREASING PROTEIN PRODUCTION IN MAMMALIAN CELLS
#493CELL CULTURE PROCESS FOR PRODUCING A PROTEIN
#494Method for preparing antibody through regulation of sugar content of antibody
#495METHOD FOR OBTAINING IMMUNOGLOBULIN ENCODING NUCLEIC ACID
#496Chemical and biochemical adducts as biomarkers for organophosphate exposure
#497Vaccination with immuno-isolated cells producing an immunomodulator
#498Methods for increasing mannose content of recombinant proteins
#499Feeding strategies and purification processes for monoclonal antibody production
#500Vaccination with immuno-isolated cells producing an immunomodulator
#501Composition of natural vitamin C and fish scale collagen peptide and preparation method thereof
#502Method for the production of domain antibodies
#503Medium containing uridine and N-acetyl-D-mannosamine
#504MODULATION OF CELL GROWTH AND GLYCOSYLATION IN RECOMBINANT GLYCOPROTEIN PRODUCTION
#505Nucleic acid molecules encoding for BACE1 antibodies
#506Chemoenzymatic glycoengineering of antibodies and Fc fragments thereof
#507METHODS TO PRODUCE SINGLE GLYCOFORM ANTIBODIES
#508METHODS FOR CONTROLLING THE GALACTOSYLATION PROFILE OF RECOMBINANTLY-EXPRESSED PROTEINS
#509Recombinant host cell for expressing proteins of interest
#510Construct and sequence for enhanced gene expression
#511PDGF receptor beta binding polypeptides
#512PROCESS FOR THE ATTACHMENT OF A GALNAC MOIETY COMPRISING A (HETERO)ARYL GROUP TO A GLCNAC MOIETY, AND PRODUCT OBTAINED THEREBY
#513EX VIVO ANTIBODY PRODUCTION
#514AGER-PEPTIDES AND USE THEREOF
#515COMPOSITIONS AND METHODS FOR ANTIBODY PRODUCTION
#516Anti-MCAM antibodies and associated methods of use
#517ANTIBODIES TO RECEPTOR OF ADVANCED GLYCATION END PRODUCTS (RAGE) AND USES THEREOF
#518Cell culture process
#519Vectors for use in an inducible coexpression system
#520IL-18 binding molecules
#521RESTRICTING NUCLEAR PROTEIN TO SPECIFIC PHASES OF THE CELL CYCLE
#522Process for modifying galactosylation and GF content of a glycoprotein composition by glutamine supplementation
#523High affinity antibody antagonists of interleukin-13 receptor alpha 1
#524MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
#525MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
#526MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
#527Antibody composition-producing cell
#528Methods for producing virus particles with simplified glycosylation of surface proteins
#529OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
#530Optimized Fc variants and methods for their generation
#531Decreasing ornithine production to decrease high mannose glycoform content of recombinant proteins
#532RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
#533Recombinant polypeptide production methods
#534Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
#535Transgenic transchromosomal rodents for making human antibodies
#536Recombinant production of mixtures of antibodies
#537Antibody identification by lineage analysis
#538Optimized Fc variants and methods for their generation
#539EPITOPES OF HERPES SIMPLEX VIRUS
#540Reduction of lipase activity in product formulations
#541Control of protein glycosylation by culture medium supplementation and cell culture process parameters
#542Methods for modulating mannose content of recombinant proteins
#543METHOD FOR PURIFYING RECOMBINANT FSH
#544Recombinant lubricin composition
#545Antibody production
#546Method for optimizing the assembly and production of hetero-multimeric protein complexes
#547METHOD OF PRODUCING GLYCOPROTEIN
#548Enzymes and methods for cleaving N-glycans from glycoproteins
#549Use of monensin to regulate glycosylation of recombinant proteins
#550Modified glycoprotein, protein-conjugate and process for the preparation thereof
#551Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
#552METHODS FOR CONTROLLING PROTEIN GLYCOSYLATION
#553Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
#554Production of recombinant proteins with simple glycoforms
#555Process for the culturing of cells
#556Recombinant glycoproteins and uses thereof
#557Neutralizing anti-influenza A antibodies and uses thereof
#558Mannosidases capable of uncapping mannose-1-phospho-6-mannose linkages and demannosylating phosphorylated N-glycans and methods of facilitating mammalian cellular uptake of glycoproteins
#559Modified glycoprotein, protein-conjugate and process for the preparation thereof
#560Control of rheological properties of mixed hyaluronate/lubricin solutions
#561Cell expression system
#562METHODS FOR MAKING PROTEINS CONTAINING FREE CYSTEINE RESIDUES
#563Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process Parameters
#564Modulated lysine variant species compositions and methods for producing and using the same
#565Activated formylglycine-generating enzymes and methods of producing and using the same
#566Mice That Produce Antigen-Binding Proteins With pH-Dependent Binding Characteristics
#567Method for the clarification of high-density crude cell culture harvest
#568IMPROVED PROCESS FOR PRODUCTION OF MONOCLONAL ANTIBODIES
#569Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
#570Methods for controlling the galactosylation profile of recombinantly-expressed proteins
#571Fusion partner for production of monoclonal rabbit antibodies
#572Cells producing Fc-containing molecules having altered glycosylation patterns and methods and use thereof
#573Method for the production of a glycosylated immunoglobulin
#574METHODS FOR MODULATING THE GLYCOSYLATION PROFILE OF RECOMBINANT PROTEINS USING SUGARS
#575Methods and means for the production of Ig-like molecules
#576OLIGOSACCHARIDE COMPOSITIONS, GLYCOPROTEINS AND METHODS TO PRODUCE THE SAME IN PROKARYOTES
#577Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#578Fibrinogen preparations enriched in fibrinogen with an extended alpha chain
#579Method of treating fibroblast growth factor 21 (FGF-21) deficiency
#580Methods for producing sialylated therapeutic proteins
#581Production of Glycoproteins Having Increased N-Glycosylation Site Occupancy
#582Modified polynucleotides for the production of proteins
#583Synthesis of sialic acid in plants
#584Methods for controlling fucosylation levels in proteins
#585Transglycosylation activity of glycosynthase mutants of an endo-beta-N-acetylglucosaminidase (endo-D) from
#586Method for preparing sialic acid derivative
#587Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods
#588Enzymatic conjugation of polypeptides
#589SIALYLATED GLYCOPROTEINS
#590Quantitative control of sialylation and specific mono-sialylation
#591DEFINED GLYCOPROTEIN PRODUCTS AND RELATED METHODS
#592Fucosylation-deficient cells
#593METHOD FOR PREPARING ANTIBODIES HAVING IMPROVED PROPERTIES
#594Quantitative control of sialylation
#595MOLECULAR LABELING METHODS
#596Methods of cell culture
#597METHODS FOR PRODUCING MODIFIED GLYCOPROTEINS
#598N-acetylhexosamine-containing N-glycans in glycoprotein products
#599Galactose-alpha-1, 3-galactose-containing n-glycans in glycoprotein products derived from CHO cells
#600Efficient selectivity of recombinant proteins